The Online Investor
Diagnostics M&A image Diagnostics M&A » By The Online Investor Staff, updated Sat., Apr. 20, 4:54 AM Recent mergers and acquisitions in the Diagnostics M&A category.

Slide #24. BioTelemetry, Inc. Mednet Healthcare Technologies, Inc.

Acquirer: BioTelemetry, Inc. (NASDAQ:BEAT)
Acquiree: Mednet Healthcare Technologies, Inc.
Details: BioTelemetry, Inc. (Nasdaq:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a significant victory in the patent infringement case against Mednet Healthcare Technologies, Inc. and its subsidiaries, Heart-Care Corporation of America, Universal Medical Inc., and Universal Medical Laboratory, Inc. ("Mednet"), as well as other named defendants. Mednet entered into a consent judgment, declaring that the Mednet entities infringed on five patents owned by BioTelemetry and its subsidiary, Braemar Manufacturing, and that all five patents are valid.

HeartBeam is a medical technology company primarily focusing on telemedicine solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. Co.'s initial focus is providing diagnostic data to help physicians with care management of patients with cardiovascular disease. Co. is developing its telehealth Product to address the field of remote patient monitoring. Co.'s telehealth Product is comprised of a credit card sized ECG machine and a cloud-based diagnostic software exert system. Co. is applying its platform technology to create a software tool for detecting heart attacks in the Emergency Room environment.

Open the BEAT Page at The Online Investor »

Company Name: 
Heartbeam Inc
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding BEAT: 
2
Total Market Value Held by ETFs: 
$1.22M
Total Market Capitalization: 
$47.00M
% of Market Cap. Held by ETFs: 
2.59%
 

Open the BEAT Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree BEAT Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
BEAT Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Diagnostics M&A - Slide 24 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.